Kamada Ltd. (KMDA)
NASDAQ: KMDA · Real-Time Price · USD
6.90
+0.07 (1.10%)
Oct 31, 2025, 3:25 PM EDT - Market open
Kamada Revenue
Kamada had revenue of $44.75M in the quarter ending June 30, 2025, with 5.37% growth. This brings the company's revenue in the last twelve months to $169.52M, up 9.67% year-over-year. In the year 2024, Kamada had annual revenue of $160.95M with 12.93% growth.
Revenue (ttm)
$169.52M
Revenue Growth
+9.67%
P/S Ratio
2.38
Revenue / Employee
$403,612
Employees
420
Market Cap
403.56M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 160.95M | 18.43M | 12.93% |
| Dec 31, 2023 | 142.52M | 13.18M | 10.19% |
| Dec 31, 2022 | 129.34M | 25.70M | 24.79% |
| Dec 31, 2021 | 103.64M | -29.60M | -22.22% |
| Dec 31, 2020 | 133.25M | 6.06M | 4.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
KMDA News
- 25 days ago - My Top 5 Biotech Stocks Big Pharma Could Buy Next - Seeking Alpha
- 2 months ago - Kamada: Earnings Expansion Cycle With Embedded Margin Of Safety - Seeking Alpha
- 2 months ago - Kamada Ltd. (KMDA) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Kamada to Announce Second Quarter and First Half Ended June 30, 2025 Financial Results on August 13, 2025 - GlobeNewsWire
- 4 months ago - Kamada Confirms Continuous Global Business Operations and Products Availability Despite Recent Events in the Middle East - GlobeNewsWire
- 6 months ago - Kamada Ltd. (KMDA) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Kamada Reports Strong First Quarter 2025 Financial Results with Year Over Year Top Line Growth of 17% and a 54% Increase in Profitability - GlobeNewsWire
- 8 months ago - Kamada Announces Expansion of Plasma Collection Operations with the Opening of New Site in San Antonio, Texas - GlobeNewsWire